Shilpa Medicare up 6%, to acquire Navya Biologicals

The company's board has approved the acquisition of Navya Biologicals in exchange for 14 lakh shares of company to be issued to the shareholders of Navya Biologicals.

June 28, 2016 / 10:05 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Moneycontrol BureauShare of Shilpa Medicare added 6.2 percent intraday Tuesday as it has approved the amalgamation of Navya Biologicals with itself.The company's board has approved the acquisition of Navya Biologicals in exchange for 14 lakh shares of company to be issued to the shareholders of Navya Biologicals.The acquisition is subject to approval from requisite authorities and will be completed in 7 to 8 months.At 09:47 hrs Shilpa Medicare was quoting at Rs 504, up Rs 19.20, or 3.96 percent on the BSE.Posted by Rakesh Patil

first published: Jun 28, 2016 10:05 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347